Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
Kern JK, Grannemann BD, Trivedi MH, Adams JB: Sulfhydryl-reactive metals in autism
Teenagers should use supplements only under medical advice
Contraception 67 , 277280 (2003)
Alpha-lipoic acid in liver metabolism and disease
It's impossible to live a life where you are never exposed to heavy metals, and it's impossible (and unnecessary) to get them 100% out of the body